lactic acid, L-, citric acid monohydrate, and potassium bitartrate

CHEBI:CHEBI_750952

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2385353
product_type
HUMAN PRESCRIPTION DRUG
marketing_category
NDA
listing_expiration_date
20241231
dosage_form
GEL
pharm_class
Calcium Chelating Activity [MoA]
package_marketing_start_date
20200901
marketing_start_date
20200801
route
VAGINAL
active_ingredient_strength
20 mg/5g
active_ingredient_name
POTASSIUM BITARTRATE
unii
NPT6P8P3UU
generic_name
lactic acid, L-, citric acid monohydrate, and potassium bitartrate
brand_name
Phexxi
brand_name_base
Phexxi
product_ndc
69751-100
application_number
NDA208352
labeler_name
Evofem, Inc.
manufacturer_name
Evofem, Inc.
spl_id
11e3cfeb-3ae2-4e97-88f9-3e4cdf770659
package_ndc
69751-100-12
package_description
12 APPLICATOR in 1 BOX (69751-100-12) / 5 g in 1 APPLICATOR (69751-100-01)
spl_set_id
173ff411-7227-47b0-94dc-844e1ebaf14e
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class